← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Universidade Federal De Minas Gerais
Belo Horizonte
$1,171,912
Total funding
6
Grants
Funding over time
peak $284.5K · FY2005–11$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,171,912 · 6
By mechanism
R01$516,427 · 2
R03$451,008 · 3
R21$204,477 · 1
Investigators at Universidade Federal De Minas Gerais
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
Largest grants
Genetic analysis of cholinergic function: implications to Alzheimer's disease.$103,743
R21 · FY2006 · TW
Genetic analysis of cholinergic function: implications to Alzheimer's disease.$100,734
R21 · FY2007 · TW
Spatial clustering pre and post-treatment for schistosomiasis and geohelminths$75,600
R03 · FY2008 · AI
The role of CD28- cells in human Chagas' disease$54,000
R03 · FY2007 · AI
Spatial clustering pre and post-treatment for schistosomiasis and geohelminths$54,000
R03 · FY2009 · AI
DOUBLE NEGATIVE, CD4-CD8- T CELLS IN HUMAN LEISHMANIASIS$54,000
R03 · FY2009 · AI
Mast cell toll-like receptors and parasitic pathogens$54,000
R01 · FY2004 · TW
DOUBLE NEGATIVE, CD4-CD8- T CELLS IN HUMAN LEISHMANIASIS$54,000
R03 · FY2008 · AI
Mast cell toll-like receptors and parasitic pathogens$54,000
R01 · FY2005 · TW
DOUBLE NEGATIVE, CD4-CD8- T CELLS IN HUMAN LEISHMANIASIS$53,460
R03 · FY2010 · AI
The role of CD28- cells in human Chagas' disease$52,974
R03 · FY2008 · AI
The role of CD28- cells in human Chagas' disease$52,974
R03 · FY2009 · AI
Mast cell toll-like receptors and parasitic pathogens$52,731
R01 · FY2006 · TW
Mast cell toll-like receptors and parasitic pathogens$51,202
R01 · FY2008 · TW
Mast cell toll-like receptors and parasitic pathogens$51,202
R01 · FY2007 · TW
Genetic susceptibility to gastric cancer in Latin America$50,760
R01 · FY2008 · TW
Genetic susceptibility to gastric cancer in Latin America$50,760
R01 · FY2010 · TW
Genetic susceptibility to gastric cancer in Latin America$50,760
R01 · FY2009 · TW
Genetic susceptibility to gastric cancer in Latin America$50,760
R01 · FY2007 · TW
Genetic susceptibility to gastric cancer in Latin America$50,252
R01 · FY2011 · TW